3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Lymphoma
2
Sarcoma
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Mixed Dementias
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Lewy Body Disease
1
Kidney Neoplasms
1
Dementia, Vascular
1
Dementia
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Breast Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
6
Cyclophosphamide
6
X-Rays
5
Phantoms, Imaging
5
Filgrastim
5
pembrolizumab
4
Specimen Handling
4
Radiotherapy
4
Nuclear Medicine Department, Hospital
4
Gemcitabine
4
Biopsy
4
tazemetostat
3
Surveys and Questionnaires
3
Psychiatric Rehabilitation
3
Etoposide
3
Drug Therapy
3
Carboplatin
3
Busulfan
3
Bevacizumab
3
ulixertinib
2
tipifarnib
2
spartalizumab
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
ganitumab
2
ensartinib
2
aflibercept
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma
×
Referral and Consultation
×
Lymphoid
×
Clear all
NCT02821793
2025-07-01
PRIORITY
Institut Bergonié
Completed
346 enrolled
9 charts